R J Bio-Tech Limited reported standalone unaudited earnings results for six months ended Sept. 30, 2017. For the period, the company reported total income from operations of INR 71.737 million, loss before extraordinary items and tax of INR 33.542 million, loss before tax of INR 33.542 million, net loss of INR 33.542 million or INR 3.54 basic and diluted per share compared to total income from operations of INR 156.437 million, loss before extraordinary items and tax of INR 22.012 million, loss before tax of INR 22.012 million, net loss of INR 22.012 million or INR 2.32 basic and diluted per share a year ago.